On February 26th, the New York State Drug Utilization Review Board will meet to review and recommend NYS Medicaid clinical criteria for Viekira Pak - the most recently approved Hepatitis C therapy - marketed by AbbVie.
Tag Archive for: Open for Comment
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
Upcoming Events
- There are no upcoming events.
News & Recent Posts
- Take Action | Preserving CDC’s Viral Hepatitis Laboratory (American Association for the Study of Liver Diseases) May 6, 2025
- Communications Committee Meeting Highlights | 04-09-2025 April 21, 2025
- NYC Hep B Coalition Meeting Highlights | 03-19-2025 April 14, 2025
- NYC Hep C Task Force Meeting Highlights | 03-26-2025 April 14, 2025
- Hepatitis Awareness Month 2025 April 1, 2025
